Differentiating Immunoglobulin G4-Related Sclerosing Cholangitis from Hilar Cholangiocarcinoma
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Few studies have differentiated immunoglobulin G (IgG) 4-related sclerosing cholangitis (IgG4-SC) from hilar cholangiocarcinoma (CC). Thus, we sought to investigate useful features for differentiating IgG4-SC from hilar CC. Methods: We retrospectively compared clinical,serological, imaging, and histological features of six patients with IgG4-SC and 42 patients with hilar CC. Results: In patients with hilar CC, obstructive jaundice was more frequent (p<0.01), serum total bilirubin levels were significantly higher (p<0.05), serum CA19-9 levels were significantly higher (p<0.01), and serum duke pancreatic monoclonal antigen type 2 levels were frequently elevated (p<0.05). However,in patients with IgG4-SC, the serum IgG (p<0.05) and IgG4(p<0.01) levels were significantly higher and frequently elevated. The pancreas was enlarged in all IgG4-SC patients but only in 17% of hilar CC patients (p<0.01). Salivary and/or lacrimal gland swelling was detected in only 50% of IgG4-SC patients (p<0.01). Endoscopic retrograde cholangiography revealed that the hilar or hepatic duct was completely obstructed in 83% of hilar CC patients (p<0.01). Lower bile duct stenosis, apart from hilar bile duct stenosis, was more frequent in IgG4-SC patients (p<0.01). Bile duct wall thickening in areas without stenosis was more frequent in IgG4-SC patients (p<0.01). Conclusions: An integrated diagnostic approach based on clinical, serological, imaging, and histological findings is necessary to differentiate IgG4-SC from hilar CC.
Abstract
Background/Aims: Few studies have differentiated immunoglobulin G (IgG) 4-related sclerosing cholangitis (IgG4-SC) from hilar cholangiocarcinoma (CC). Thus, we sought to investigate useful features for differentiating IgG4-SC from hilar CC. Methods: We retrospectively compared clinical,serological, imaging, and histological features of six patients with IgG4-SC and 42 patients with hilar CC. Results: In patients with hilar CC, obstructive jaundice was more frequent (p<0.01), serum total bilirubin levels were significantly higher (p<0.05), serum CA19-9 levels were significantly higher (p<0.01), and serum duke pancreatic monoclonal antigen type 2 levels were frequently elevated (p<0.05). However,in patients with IgG4-SC, the serum IgG (p<0.05) and IgG4(p<0.01) levels were significantly higher and frequently elevated. The pancreas was enlarged in all IgG4-SC patients but only in 17% of hilar CC patients (p<0.01). Salivary and/or lacrimal gland swelling was detected in only 50% of IgG4-SC patients (p<0.01). Endoscopic retrograde cholangiography revealed that the hilar or hepatic duct was completely obstructed in 83% of hilar CC patients (p<0.01). Lower bile duct stenosis, apart from hilar bile duct stenosis, was more frequent in IgG4-SC patients (p<0.01). Bile duct wall thickening in areas without stenosis was more frequent in IgG4-SC patients (p<0.01). Conclusions: An integrated diagnostic approach based on clinical, serological, imaging, and histological findings is necessary to differentiate IgG4-SC from hilar CC.
참고문헌 (26)
- Okazaki K, "Japanese clinical guidelines for autoimmune pancreatitis", Pancreas, 38, pp.849~866 (2009)
- Kamisawa T, "Autoimmune pancreatitis and IgG4-related sclerosing disease", Nat Rev Gastroenterol Hepatol, 7, pp.401~409 (2010)
- Nakazawa T, "Diagnostic procedures for IgG4-related sclerosing cholangitis", J Hepatobiliary Pancreat Sci, 18, pp.127~136 (2011)
- Kamisawa T, "Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis", World J Gastroenterol, 15, pp.2357~2360 (2009)
- Ghazale A, "Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy", Gastroenterology, 134, pp.706~715 (2008)
- Nakazawa T, "Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis", Gastrointest Endosc, 60, pp.937~944 (2004)
- Naitoh I, "Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis", J Gastroenterol, 44, pp.1147~1155 (2009)
- Kawakami H, "IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct", J Gastroenterol Hepatol, 25, pp.1648~1655 (2010)
- Oseini AM, "Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma", Hepatology, 54, pp.940~948 (2011)
- Hamano H, "Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?", Gastrointest Endosc, 62, pp.152~157 (2005)
- Shimosegawa T, "International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology", Pancreas, 40, pp.352~358 (2011)
- Haaga JR, "Computed tomography of the pancreas", Radiology, 120, pp.589~595 (1976)
- Gerhards MF, "Incidence of benign lesions in patients resected for suspicious hilar obstruction", Br J Surg, 88, pp.48~51 (2001)
- Koea J, "Differential diagnosis of stenosing lesions at the hepatic hilus", World J Surg, 28, pp.466~470 (2004)
- Corvera CU, "Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma", J Am Coll Surg, 201, pp.862~869 (2005)
- Erdogan D, "Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures", Br J Surg, 95, pp.727~734 (2008)
- Hirano K, "Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis", Gastrointest Endosc, 71, pp.85~90 (2010)
- Chari ST, "A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer", Clin Gastroenterol Hepatol, 7, pp.1097~1103 (2009)
- Hirano K, "Involvement of the biliary system in autoimmune pancreatitis: a follow-up study", Clin Gastroenterol Hepatol, 1, pp.453~464 (2003)
- Oh HC, "Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis", Intern Med, 47, pp.2025~2028 (2008)
- Straub BK, "IgG4-associated cholangitis with cholangiocarcinoma", Virchows Arch, 458, pp.761~765 (2011)
- Nakazawa T, "Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification", J Gastroenterol, 47, pp.79~87 (2012)
- Kamisawa T, "Sclerosing cholecystitis associated with autoimmune pancreatitis", World J Gastroenterol, 12, pp.3736~3739 (2006)
- Leise MD, "IgG4-associated cholecystitis: another clue in the diagnosis of autoimmune pancreatitis", Dig Dis Sci, 56, pp.1290~1294 (2011)
- Weber A, "Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma", World J Gastroenterol, 14, pp.1097~1101 (2008)
- Oh HC, "Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma", J Gastroenterol Hepatol, 25, pp.1831~1837 (2010)